Chemed (CHE) Asset Writedowns and Impairment (2009 - 2020)

Chemed's Asset Writedowns and Impairment history runs 10 years deep, the most recent figure standing at -$443000.0 for Q4 2020.

• In Q4 2020, Asset Writedowns and Impairment changed N/A year-over-year to -$443000.0; the TTM figure through Dec 2020 stood at $601000.0 (changed N/A YoY), while the FY2020 annual figure was $657000.0, changed N/A from the prior year.
• Asset Writedowns and Impairment was -$443000.0 for Q4 2020 at Chemed, down from $185000.0 in the prior quarter.
• In the past five years, Asset Writedowns and Impairment ranged from a high of $4.7 million in Q3 2017 to a low of -$443000.0 in Q4 2020.
• Historically, Asset Writedowns and Impairment has averaged $2.9 million across 3 years, with a median of $4.0 million in 2016.
• Biggest YoY gain for Asset Writedowns and Impairment was 33.05% in 2016; the steepest drop was 1.22% in 2016.
• A 3-year view of Asset Writedowns and Impairment shows it stood at $4.2 million in 2016, then climbed by 3.96% to $4.4 million in 2017, then sank by 110.18% to -$443000.0 in 2020.
• The last three Asset Writedowns and Impairment figures came in at -$443000.0 (Q4 2020), $185000.0 (Q3 2020), and $265000.0 (Q2 2020), per Business Quant data.